Welcome to Paid Research Studies




  • Condition:   Hodgkin Lymphoma
    Interventions:   Drug: bendamustine;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Bleomycin;   Drug: Vincristine;   Drug: Vinblastine;   Drug: Prednisone;   Drug: Filgrastim;   Drug: Brentuximab Vedotin;   Drug: Cyclophosphamide;   Drug: DTIC;   Other: Quality of Life Measurements;   Radiation: Radiotherapy
    Sponsors:   St. Jude Children's Research Hospital;   Teva Pharmaceuticals USA;   Seattle Genetics, Inc.
    Recruiting

  • Conditions:   Ovarian Granulosa Cell Tumor;   Ovarian Gynandroblastoma;   Ovarian Sertoli-Leydig Cell Tumor;   Ovarian Sex Cord Tumor With Annular Tubules;   Ovarian Sex Cord-Stromal Tumor;   Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types;   Ovarian Steroid Cell Tumor
    Interventions:   Biological: Bleomycin Sulfate;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide Phosphate;   Other: Laboratory Biomarker Analysis;   Drug: Paclitaxel
    Sponsors:   Gynecologic Oncology Group;   National Cancer Institute (NCI)
    Recruiting

  • Conditions:   Adult Germ Cell Tumor;   Childhood Extracranial Germ Cell Tumor;   Childhood Germ Cell Tumor;   Extragonadal Embryonal Carcinoma;   Grade 2 Immature Ovarian Teratoma;   Grade 3 Immature Ovarian Teratoma;   Malignant Germ Cell Tumor;   Stage I Ovarian Choriocarcinoma;   Stage I Ovarian Embryonal Carcinoma;   Stage I Ovarian Teratoma;   Stage I Ovarian Yolk Sac Tumor;   Stage I Testicular Choriocarcinoma AJCC v6 and v7;   Stage I Testicular Embryonal Carcinoma AJCC v6 and v7;   Stage I Testicular Yolk Sac Tumor AJCC v6 and v7;   Stage II Ovarian Choriocarcinoma;   Stage II Ovarian Embryonal Carcinoma;   Stage II Ovarian Yolk Sac Tumor;   Stage II Testicular Choriocarcinoma AJCC v6 and v7;   Stage II Testicular Embryonal Carcinoma AJCC v6 and v7;   Stage II Testicular Yolk Sac Tumor AJCC v6 and v7;   Stage III Ovarian Choriocarcinoma;   Stage III Ovarian Embryonal Carcinoma;   Stage III Ovarian Yolk Sac Tumor;   Stage III Testicular Choriocarcinoma AJCC v6 and v7;   Stage III Testicular Embryonal Carcinoma AJCC v6 and v7;   Stage III Testicular Yolk Sac Tumor AJCC v6 and v7;   Stage IV Ovarian Choriocarcinoma;   Stage IV Ovarian Embryonal Carcinoma;   Stage IV Ovarian Yolk Sac Tumor;   Testicular Mixed Choriocarcinoma and Embryonal Carcinoma;   Testicular Mixed Choriocarcinoma and Teratoma;   Testicular Mixed Choriocarcinoma and Yolk Sac Tumor
    Interventions:   Other: Best Practice;   Drug: Bleomycin;   Biological: Bleomycin Sulfate;   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Etoposide;   Drug: Etoposide Phosphate;   Other: Laboratory Biomarker Analysis;   Other: Pharmacogenomic Study;   Other: Quality-of-Life Assessment;   Other: Questionnaire Administration
    Sponsors:   Children's Oncology Group;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Hodgkin Lymphoma
    Interventions:   Biological: pembrolizumab;   Drug: doxorubicin;   Drug: vinblastine;   Drug: dacarbazine;   Drug: cyclophosphamide;   Drug: vincristine;   Drug: prednisone/prednisolone;   Drug: bleomycin;   Drug: etoposide;   Radiation: Radiotherapy (RT)
    Sponsor:   Merck Sharp & Dohme Corp.
    Recruiting

  • Conditions:   Urothelial Carcinoma;   Bladder Cancer;   Urinary Bladder Neoplasms
    Interventions:   Drug: 75 approved agents;   Other: COXEN
    Sponsor:   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Hodgkin Lymphoma
    Interventions:   Drug: doxorubicin;   Drug: Bleomycin;   Drug: vinblastine;   Drug: dacarbazine;   Drug: Nivolumab
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Bristol-Myers Squibb;   Barbara Ann Karmanos Cancer Institute;   British Columbia Cancer Agency
    Recruiting

  • Conditions:   Ann Arbor Stage IB Hodgkin Lymphoma;   Ann Arbor Stage II Hodgkin Lymphoma;   Ann Arbor Stage IIA Hodgkin Lymphoma;   Ann Arbor Stage IIB Hodgkin Lymphoma;   Ann Arbor Stage III Hodgkin Lymphoma;   Ann Arbor Stage IIIA Hodgkin Lymphoma;   Ann Arbor Stage IIIB Hodgkin Lymphoma;   Ann Arbor Stage IV Hodgkin Lymphoma;   Ann Arbor Stage IVA Hodgkin Lymphoma;   Ann Arbor Stage IVB Hodgkin Lymphoma;   Classic Hodgkin Lymphoma
    Interventions:   Drug: Brentuximab Vedotin;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
    Sponsors:   Academic and Community Cancer Research United;   National Cancer Institute (NCI)
    Recruiting

  • Condition:   Hodgkin Lymphoma
    Interventions:   Drug: Stanford V Chemotherapy;   Radiation: Radiation Therapy
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting

  • Conditions:   Ann Arbor Stage I Hodgkin Lymphoma;   Ann Arbor Stage I Lymphocyte-Depleted Classic Hodgkin Lymphoma;   Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma;   Ann Arbor Stage I Nodular Sclerosis Classic Hodgkin Lymphoma;   Ann Arbor Stage IA Hodgkin Lymphoma;   Ann Arbor Stage IB Hodgkin Lymphoma;   Ann Arbor Stage II Hodgkin Lymphoma;   Ann Arbor Stage II Lymphocyte-Depleted Classic Hodgkin Lymphoma;   Ann Arbor Stage II Mixed Cellularity Classic Hodgkin Lymphoma;   Ann Arbor Stage II Nodular Sclerosis Classic Hodgkin Lymphoma;   Ann Arbor Stage IIA Hodgkin Lymphoma;   Ann Arbor Stage IIB Hodgkin Lymphoma;   Classic Hodgkin Lymphoma;   Lymphocyte-Rich Classic Hodgkin Lymphoma
    Interventions:   Drug: Bleomycin;   Drug: Brentuximab Vedotin;   Drug: Dacarbazine;   Drug: Doxorubicin;   Biological: Nivolumab;   Other: Quality-of-Life Assessment;   Drug: Vinblastine
    Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting